Author Archives: Scalper1

Luxoft Attacks Vertical Markets, But Under The Radar

Swiss tech service provider Luxoft has been a top performer in its sector, with its international and vertical-market approach. Luxoft (LXFT) has a highest-possible IBD Composite Rating of 99, a rating that its groupmate Cognizant Technology Solutions (CTSH) shares. IBD’s tech services group, which also includes Accenture (ACN) and Infosys (INFY), ranks No. 23 out of 197. Luxoft’s focus is vertical, developing software tailored for customers in

Facebook’s Instagram Reaches 400 Million Users

Facebook (FB) says its photo and video sharing app Instagram has achieved a new milestone — hitting 400 million users. That’s up from 300 million as recently as December, says Facebook of the service that it bought in 2012 for more than $700 million. Instagram users now share some 80 million photos a day, the messaging service said. Much of the growth is coming from overseas. More than 75% of Instagram users live outside of the U.S., and more than

Heron Therapeutics Stock Soars On Pain Drug Success

Heron Therapeutics (HRTX) stock soared Wednesday after the biotech company reported success late Tuesday in a midstage trial of its drug for post-operative pain. Heron’s phase two study treated 64 patients who’d undergone a bunion removal. Those who took a 400 mg dose of Heron’s candidate HTX-011 showed a 69% reduction in pain intensity in the first 24 hours compared with the placebo group, and a 40% reduction after 72 hours. Patients on the drug